The cardiovascular drug market has seen big developments in recent years, as warfarin and old-line statins have given way to next-generation blood thinners and novel, high-priced cholesterol fighters.

As a new age of price negotiations dawns in the U.S., drug cost watchdogs at the Institute for Clinical and Economic Review (ICER) are laying out their stance on two popular blood thinners. Monday, ...

Nov 16 (Reuters) - Eliquis, a promising blood clot preventer from Bristol-Myers Squibb and Pfizer, has a decent chance at getting an accelerated review by U.S. health regulators in coming months, ...

Pradaxa (dabigatran) is a brand-name drug that’s prescribed to help treat or prevent blood clots. The medication is available in these forms: oral pellets and oral capsules. The cost of Pradaxa with ...